Antimicrobial Resistance Among Bacterial Pathogens in Nigeria: A Systematic Review and Meta-Analysis, 2015–2026

Antimicrobial resistance (AMR) has become a significant public health issue in Nigeria, and reported variability is extremely high across bacterial pathogens, antimicrobial agents, and geographical and clinical settings. This meta-analysis and systematic review summarized the existing evidence on AMR in bacterial pathogens in Nigeria from 2015 to 2026. Relevant literature indicating antimicrobial resistance in bacterial pathogens derived from human clinical samples in Nigeria was searched and reviewed systematically. Bacterial pathogen, antimicrobial data, geographical and clinical settings and percentages of resistance were extracted. Meta-analysis based on restricted maximum likelihood estimation and inverse-variance weighting was carried out as a random-effects analysis. The subgroup analyses were done based on pathogen, antimicrobial agent, geographical location and clinical setting. Temporal patterns in AMR were measured with the use of publication year as a continuous moderator by meta-regression. A total of 147 resistance estimates were identified, of which 138 (93.9%) were included in the meta-analysis. The overall pooled prevalence of AMR was 70.7% (95% CI: 63.9–76.7%), with substantial heterogeneity (I² = 97.7%). Pooled resistance was found to differ among pathogens, with the highest being 31.7% with Proteus vulgaris and the lowest 86.1% for Klebsiella oxytoca. Resistance also differed significantly among antimicrobial agents; the pooled estimates for penicillin G, linezolid, colistin, doripenem, ceftazidime and ciprofloxacin are high. Hospital estimates had the highest pooled resistance (87.1%), and outpatient estimates were the least resistant (50.1%). The pooled prevalence in the South-West was 73.1%. The meta-regression revealed the lack of a significant correlation between publication year and AMR prevalence (β = 0.003, p = 0.990). The prevalence of AMR in bacterial pathogens in Nigeria was high, and there was large variation in the AMR of pathogens, antimicrobial agents, geographical areas and clinical environments. Stronger surveillance, antimicrobial stewardship and standardized reporting are required to tackle the continuing AMR disease burden.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-12
DOI
https://doi.org/10.5281/zenodo.24160978
Primary Topic
Antibiotic Use and Resistance
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Antimicrobial Resistance Among Bacterial Pathogens in Nigeria: A Systematic Review and Meta-Analysis, 2015–2026

Balogun K. B.
Zenodo (CERN European Organization for Nuclear Research)
Antibiotic Use and Resistance
article

Antimicrobial Resistance Among Bacterial Pathogens in Nigeria: A Systematic Review and Meta-Analysis, 2015–2026

Balogun K. B.
article en

Abstract

Antimicrobial resistance (AMR) has become a significant public health issue in Nigeria, and reported variability is extremely high across bacterial pathogens, antimicrobial agents, and geographical and clinical settings. This meta-analysis and systematic review summarized the existing evidence on AMR in bacterial pathogens in Nigeria from 2015 to 2026. Relevant literature indicating antimicrobial resistance in bacterial pathogens derived from human clinical samples in Nigeria was searched and reviewed systematically. Bacterial pathogen, antimicrobial data, geographical and clinical settings and percentages of resistance were extracted. Meta-analysis based on restricted maximum likelihood estimation and inverse-variance weighting was carried out as a random-effects analysis. The subgroup analyses were done based on pathogen, antimicrobial agent, geographical location and clinical setting. Temporal patterns in AMR were measured with the use of publication year as a continuous moderator by meta-regression. A total of 147 resistance estimates were identified, of which 138 (93.9%) were included in the meta-analysis. The overall pooled prevalence of AMR was 70.7% (95% CI: 63.9–76.7%), with substantial heterogeneity (I² = 97.7%). Pooled resistance was found to differ among pathogens, with the highest being 31.7% with Proteus vulgaris and the lowest 86.1% for Klebsiella oxytoca. Resistance also differed significantly among antimicrobial agents; the pooled estimates for penicillin G, linezolid, colistin, doripenem, ceftazidime and ciprofloxacin are high. Hospital estimates had the highest pooled resistance (87.1%), and outpatient estimates were the least resistant (50.1%). The pooled prevalence in the South-West was 73.1%. The meta-regression revealed the lack of a significant correlation between publication year and AMR prevalence (β = 0.003, p = 0.990). The prevalence of AMR in bacterial pathogens in Nigeria was high, and there was large variation in the AMR of pathogens, antimicrobial agents, geographical areas and clinical environments. Stronger surveillance, antimicrobial stewardship and standardized reporting are required to tackle the continuing AMR disease burden.

Zenodo (CERN European Organization for Nuclear Research)
University of Ibadan (NG)
Good health and well-being
Antibiotic Use and Resistance
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon